Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer - Heck, M M; Tauber, R; Schwaiger, S (Eur Urol, 2019)
et al.